We further classified patients in the initial diagnosis group into three experimental groups: the patient group with AML caused by RUNX1-RUNX1T1 translocation (n = 4), the group with AML caused by FLT3-ITD/TKD mutation (n = 4), and the group with AML induced by other causes. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.